Identification of a novel A allele with a c.731T>C mutation on the ABO*A1.02 allele

Xiaozhen Hong^{1

2}, Yanling Ying^{1

2}, Kairong Ma^{1

2}, Xianguo Xu^{1

2}, Ji He^{1

2}, Faming Zhu^{1

2}

Affiliations

¹ Transfusion Research Institute, Blood Center of Zhejiang Province, Hangzhou, China.
² Zhejiang Provincial Key Laboratory of Blood Safety Research, Hangzhou, China.

Xiaozhen Hong et al. Transfusion. 2020 Aug.

. 2020 Aug;60(8):E30-E31.

doi: 10.1111/trf.15902. Epub 2020 Jul 3.

Xiaozhen Hong^{1

2}, Yanling Ying^{1

2}, Kairong Ma^{1

2}, Xianguo Xu^{1

2}, Ji He^{1

2}, Faming Zhu^{1

2}

¹ Transfusion Research Institute, Blood Center of Zhejiang Province, Hangzhou, China.
² Zhejiang Provincial Key Laboratory of Blood Safety Research, Hangzhou, China.

No abstract available

References

1. Simmons DP, Savage WJ. Hemolysis from ABO incompatibility. Hematol Oncol Clin North Am 2015;29:42-443.
1. Dean CL, Sullivan HC, Stowell SR, et al. Current state of transfusion practices for ABO-incompatible pediatric heart transplant patients in the United States and Canada. Transfusion 2018;58:2243-9.
1. Ying Y, Hong X, Xu X, et al. A novel mutation +5904 C>T of RUNX1 site in the erythroid cell-specific regulatory element decreases the ABO antigen expression in Chinese population. Vox Sang 2018;113:594-600.
1. Ying Y, Chen S, Ma K, et al. Identification of a novel B allele with missense mutation (c.98G>C) in the ABO gene. Transfusion 2017;57:219-20.
1. Hong X, Chen S, Ma K, et al. c.830T>C mutation on the ABO*A1.02 allele responsible for Aw phenotype. Transfusion 2019;59:E11-2.